Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 60 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Hydroxychloroquine and Gefitinib to Treat Lung CancerStatus unknownNCT00809237Phase 1/2
• Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain MetastasesTerminatedNCT00807170Phase 1
• Randomized Gefitinib TrialCompletedNCT00807066Phase 3
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00806923Phase 3
• Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced RashWithdrawnNCT00803842Not applicable
• Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyStatus unknownNCT00801385Phase 2
• DNA Repair Genes and Outcomes in Patients With Stage III NSCLCStatus unknownNCT00797238
• Temsirolimus and Radiation for Non-Small Cell Lung CancerCompletedNCT00796796Phase 1
• Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00793208Phase 1
• Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLCStatus unknownNCT00786331Phase 2
• Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00783471Phase 2
• Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00777699Phase 1
• A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00777309Phase 2
• A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00776698Phase 1
• TAilored Post-Surgical Therapy in Early Stage NSCLCCompletedNCT00775385Phase 2/3
• Adjuvant Pazopanib in Stage I NSCLCCompletedNCT00775307Phase 2/3
• A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00773188Phase 1
• Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)CompletedNCT00771563Phase 3
• A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and PaclitaxelWithdrawnNCT00768131Phase 2
• Phase II Avastin Trial for Stage IIIB/IV NSCLCTerminatedNCT00766246Phase 2
• Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving BisphosphonatesCompletedNCT00765687Phase 4
• Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00763607
• Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone MetastasisCompletedNCT00762346Phase 4
• Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.Status unknownNCT00759382
• Trastuzumab Therapy in Non-Small Cell Lung Cancer PatientsTerminatedNCT00758134Phase 2
• Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerCompletedNCT00755170Phase 2
• Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly PatientsTerminatedNCT00754364Phase 2
• Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00753909Phase 2
• Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00752115Phase 2/3
• Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung CancerTerminatedNCT00749567Phase 2
• NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung CancerCompletedNCT00749346Phase 1/2
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerWithdrawnNCT00748163Phase 2
• Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00745732Phase 1
• A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLCCompletedNCT00743938Phase 2
• Pemetrexed Plus Bevacizumab in Non Small Cell Lung CancerCompletedNCT00741221Phase 2
• Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung CancerCompletedNCT00741195Phase 2
• A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and ChemotherapyCompletedNCT00738452Phase 1
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerTerminatedNCT00738387Phase 3
• Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
• Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung CancerCompletedNCT00737867Phase 3
• First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
• SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)CompletedNCT00732810Phase 2
• Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT00732563Not applicable
• Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung CancerCompletedNCT00731952Phase 1
• Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)CompletedNCT00729742Phase 1
• Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.Status unknownNCT00727350Phase 2
• Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerStatus unknownNCT00722969Phase 2
• An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing ChemotherapyTerminatedNCT00721981
• Natural Killer Cells and Bortezomib to Treat CancerCompletedNCT00720785Phase 1
• A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or ErlotinibCompletedNCT00717847
• Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility StudyCompletedNCT00717002
• Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00716534Phase 2
• Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00714246Phase 1
• Study Of SU011248 In Combination With Docetaxel In Patients With Advanced CancerCompletedNCT00712504Phase 1
• Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00708812Phase 2
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerCompletedNCT00707304Phase 3
• Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerTerminatedNCT00707252Phase 1
• Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung CancerStatus unknownNCT00706862Phase 3
• Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
• Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid TumorsWithdrawnNCT00704392Phase 1
• Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
• Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
• Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerCompletedNCT00702182Phase 1
• Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung CancerTerminatedNCT00701870Phase 2
• Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLCStatus unknownNCT00697333Phase 2
• A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung CancerWithdrawnNCT00697060Phase 2
• The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
• Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00692640Phase 1
• Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLCTerminatedNCT00692380Phase 1
• Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory GatingStatus unknownNCT00690963Phase 1/2
• Radiofrequency Ablation of Pulmonary Tumors Response EvaluationCompletedNCT00690703Phase 2
• Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
• Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)CompletedNCT00686322Phase 4
• An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and NeckApproved for marketingNCT00684385
• Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00684099Phase 1/2
• Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung CancerCompletedNCT00683514Phase 3
• Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further TreatmentApproved for marketingNCT00683306
• Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00682383Phase 2
• The Effect of Berries on Lung Cancer TumorsTerminatedNCT00681512Not applicable
• A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung CancerCompletedNCT00680940Phase 2
• A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid TumorsCompletedNCT00678977Phase 1
• Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00678964Phase 2
• Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line ChemotherapyCompletedNCT00676507Phase 3
• Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerStatus unknownNCT00674258Phase 1/2
• An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00674102Phase 1
• Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerStatus unknownNCT00673777Phase 1/2
• Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentCompletedNCT00673569Phase 2
• Angiogenesis With Positron Emission Tomography (PET) Tracer UptakeCompletedNCT00671242
• NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or LymphomaCompletedNCT00667082Phase 1
• A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00666692Phase 1
• Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00663689Phase 2
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerTerminatedNCT00662597Phase 3
• Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction ChemotherapyTerminatedNCT00661011Phase 2
• Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
• A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras MutationCompletedNCT00655161Phase 2
• A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00654758Phase 1
• Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00652561Phase 2
• Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00651508Phase 2
• CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung CancerStatus unknownNCT00643318Phase 2

← Carcinoma, Non-Small-Cell Lung overview